Qlucore targets Japanese markets.

Qlucore has partnered with Filgen Inc, one of Japan's leading specialists in sales of science research equipment to extend marketing operations of its Omics Explorer data analysis tool.

Japan's biotech market is home to over 1,000 bio-based companies and accounts for revenues of more than 25 trillion yen (£190bn) according to ArgosBiotech directory.

"Japan currently represents the third largest biotech market in the world after the US and the EU, and so this is clearly a very important opportunity for us," said Carl-Johan Ivarsson, President, Qlucore. "We are delighted to be entering into this agreement with Filgen, as we are confident that this cooperation will help researchers in Japan to learn more about our software, and to achieve extraordinary results with their data analysis."

"We have no doubt that Qlucore Omics Explorer will be very attractive to the scientific community in Japan," "The biotech and pharmaceutical sectors in Japan are growing very quickly, which means that there is a strong demand for truly innovative solutions in these areas. We therefore expect to promote Qlucore's software with great success," added Hidekatsu Yoneda, Director, Filgen, Inc.